nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—digestive system—autistic disorder	0.0218	0.0665	CbGeAlD
Carfilzomib—PSMB10—head—autistic disorder	0.0178	0.0542	CbGeAlD
Carfilzomib—PSMB10—nervous system—autistic disorder	0.0169	0.0514	CbGeAlD
Carfilzomib—PSMB5—telencephalon—autistic disorder	0.0163	0.0496	CbGeAlD
Carfilzomib—PSMB10—central nervous system—autistic disorder	0.0162	0.0495	CbGeAlD
Carfilzomib—PSMB10—cerebellum—autistic disorder	0.0159	0.0484	CbGeAlD
Carfilzomib—PSMB1—eye—autistic disorder	0.0156	0.0475	CbGeAlD
Carfilzomib—PSMB2—eye—autistic disorder	0.0152	0.0464	CbGeAlD
Carfilzomib—PSMB2—forebrain—autistic disorder	0.0151	0.046	CbGeAlD
Carfilzomib—PSMB1—telencephalon—autistic disorder	0.0142	0.0433	CbGeAlD
Carfilzomib—PSMB2—telencephalon—autistic disorder	0.0139	0.0423	CbGeAlD
Carfilzomib—PSMB10—brain—autistic disorder	0.0129	0.0393	CbGeAlD
Carfilzomib—PSMB1—digestive system—autistic disorder	0.0108	0.0331	CbGeAlD
Carfilzomib—PSMB2—digestive system—autistic disorder	0.0106	0.0323	CbGeAlD
Carfilzomib—PSMB5—cerebellum—autistic disorder	0.00903	0.0275	CbGeAlD
Carfilzomib—PSMB1—head—autistic disorder	0.00885	0.027	CbGeAlD
Carfilzomib—PSMB2—head—autistic disorder	0.00863	0.0263	CbGeAlD
Carfilzomib—PSMB1—nervous system—autistic disorder	0.00839	0.0256	CbGeAlD
Carfilzomib—PSMB8—brain—autistic disorder	0.0083	0.0253	CbGeAlD
Carfilzomib—PSMB2—nervous system—autistic disorder	0.00818	0.025	CbGeAlD
Carfilzomib—PSMB1—central nervous system—autistic disorder	0.00807	0.0246	CbGeAlD
Carfilzomib—PSMB1—cerebellum—autistic disorder	0.00789	0.0241	CbGeAlD
Carfilzomib—PSMB2—central nervous system—autistic disorder	0.00788	0.024	CbGeAlD
Carfilzomib—PSMB2—cerebellum—autistic disorder	0.0077	0.0235	CbGeAlD
Carfilzomib—PSMB5—brain—autistic disorder	0.00733	0.0224	CbGeAlD
Carfilzomib—PSMB1—brain—autistic disorder	0.00641	0.0196	CbGeAlD
Carfilzomib—PSMB2—brain—autistic disorder	0.00625	0.0191	CbGeAlD
Carfilzomib—ABCB1—forebrain—autistic disorder	0.0023	0.00702	CbGeAlD
Carfilzomib—ABCB1—telencephalon—autistic disorder	0.00212	0.00646	CbGeAlD
Carfilzomib—ABCB1—digestive system—autistic disorder	0.00162	0.00493	CbGeAlD
Carfilzomib—ABCB1—head—autistic disorder	0.00132	0.00402	CbGeAlD
Carfilzomib—ABCB1—nervous system—autistic disorder	0.00125	0.00381	CbGeAlD
Carfilzomib—ABCB1—central nervous system—autistic disorder	0.0012	0.00367	CbGeAlD
Carfilzomib—ABCB1—cerebellum—autistic disorder	0.00118	0.00359	CbGeAlD
Carfilzomib—ABCB1—brain—autistic disorder	0.000955	0.00291	CbGeAlD
Carfilzomib—PSMB9—Immune System—IL2—autistic disorder	8.76e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APC—autistic disorder	8.75e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APC—autistic disorder	8.75e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APC—autistic disorder	8.75e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF2—autistic disorder	8.74e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF2—autistic disorder	8.74e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF2—autistic disorder	8.74e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—autistic disorder	8.73e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTHFR—autistic disorder	8.73e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTHFR—autistic disorder	8.73e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTHFR—autistic disorder	8.73e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AVP—autistic disorder	8.66e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGF—autistic disorder	8.65e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGF—autistic disorder	8.65e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGF—autistic disorder	8.65e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APC—autistic disorder	8.63e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF2—autistic disorder	8.62e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTHFR—autistic disorder	8.6e-05	0.000128	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC25A12—autistic disorder	8.58e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGF—autistic disorder	8.53e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PRKCB—autistic disorder	8.45e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PRKCB—autistic disorder	8.41e-05	0.000125	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC19A1—autistic disorder	8.35e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PTEN—autistic disorder	8.28e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PLA2G4A—autistic disorder	8.26e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PLA2G4A—autistic disorder	8.26e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PLA2G4A—autistic disorder	8.26e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PTEN—autistic disorder	8.24e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—SERPINE1—autistic disorder	8.2e-05	0.000122	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—SERPINE1—autistic disorder	8.2e-05	0.000122	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—SERPINE1—autistic disorder	8.2e-05	0.000122	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PLA2G4A—autistic disorder	8.14e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOE—autistic disorder	8.12e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOE—autistic disorder	8.12e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOE—autistic disorder	8.12e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PIK3CG—autistic disorder	8.09e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APC—autistic disorder	8.09e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—SERPINE1—autistic disorder	8.08e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APC—autistic disorder	8.05e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PIK3CG—autistic disorder	8.05e-05	0.00012	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MEF2C—autistic disorder	8.03e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MEF2C—autistic disorder	8.03e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MEF2C—autistic disorder	8.03e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOE—autistic disorder	8.01e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGF—autistic disorder	8e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGF—autistic disorder	7.96e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MEF2C—autistic disorder	7.92e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ITGB3—autistic disorder	7.83e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ITGB3—autistic disorder	7.83e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ITGB3—autistic disorder	7.83e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ITGB3—autistic disorder	7.72e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—POMC—autistic disorder	7.7e-05	0.000115	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	7.68e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—POMC—autistic disorder	7.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTEN—autistic disorder	7.65e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTEN—autistic disorder	7.61e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SERPINE1—autistic disorder	7.61e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SERPINE1—autistic disorder	7.61e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SERPINE1—autistic disorder	7.61e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BCL2—autistic disorder	7.58e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BCL2—autistic disorder	7.58e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BCL2—autistic disorder	7.58e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—autistic disorder	7.51e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—autistic disorder	7.51e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—autistic disorder	7.51e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SERPINE1—autistic disorder	7.5e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BCL2—autistic disorder	7.47e-05	0.000111	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADSL—autistic disorder	7.44e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF1—autistic disorder	7.41e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—autistic disorder	7.4e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF1—autistic disorder	7.37e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—autistic disorder	7.35e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PIK3CG—autistic disorder	7.33e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PIK3CG—autistic disorder	7.33e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PIK3CG—autistic disorder	7.33e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—autistic disorder	7.31e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR2A—autistic disorder	7.31e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR2A—autistic disorder	7.31e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR2A—autistic disorder	7.31e-05	0.000109	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—XDH—autistic disorder	7.3e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PIK3CG—autistic disorder	7.23e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR2A—autistic disorder	7.2e-05	0.000107	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—STX1A—autistic disorder	7.16e-05	0.000107	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NPAS2—autistic disorder	7.16e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SERPINE1—autistic disorder	7.03e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SERPINE1—autistic disorder	7e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—POMC—autistic disorder	6.98e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—POMC—autistic disorder	6.98e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—POMC—autistic disorder	6.98e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TSC2—autistic disorder	6.94e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TSC2—autistic disorder	6.94e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TSC2—autistic disorder	6.94e-05	0.000103	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TCN2—autistic disorder	6.92e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—POMC—autistic disorder	6.88e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TSC2—autistic disorder	6.84e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOE—autistic disorder	6.79e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOE—autistic disorder	6.79e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEP—autistic disorder	6.79e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEP—autistic disorder	6.79e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEP—autistic disorder	6.79e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOE—autistic disorder	6.79e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HRAS—autistic disorder	6.76e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HRAS—autistic disorder	6.76e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HRAS—autistic disorder	6.76e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—MAPK1—autistic disorder	6.74e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MAPK1—autistic disorder	6.7e-05	9.97e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOE—autistic disorder	6.7e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEP—autistic disorder	6.7e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—autistic disorder	6.67e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—autistic disorder	6.67e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—autistic disorder	6.67e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HRAS—autistic disorder	6.66e-05	9.91e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—autistic disorder	6.65e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—autistic disorder	6.65e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—autistic disorder	6.65e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADA—autistic disorder	6.6e-05	9.82e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	6.6e-05	9.81e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—autistic disorder	6.58e-05	9.79e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—autistic disorder	6.55e-05	9.75e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PRKCB—autistic disorder	6.41e-05	9.53e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PRKCB—autistic disorder	6.41e-05	9.53e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PRKCB—autistic disorder	6.41e-05	9.53e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTEN—autistic disorder	6.41e-05	9.53e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTEN—autistic disorder	6.38e-05	9.48e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PRKCB—autistic disorder	6.32e-05	9.4e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PTEN—autistic disorder	6.28e-05	9.34e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PTEN—autistic disorder	6.28e-05	9.34e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PTEN—autistic disorder	6.28e-05	9.34e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	6.24e-05	9.29e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—MAPK1—autistic disorder	6.22e-05	9.25e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PTEN—autistic disorder	6.19e-05	9.21e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—MAPK1—autistic disorder	6.19e-05	9.21e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PIK3CG—autistic disorder	6.13e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APC—autistic disorder	6.13e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PIK3CG—autistic disorder	6.13e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APC—autistic disorder	6.13e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APC—autistic disorder	6.13e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PIK3CG—autistic disorder	6.13e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGF—autistic disorder	6.06e-05	9.02e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGF—autistic disorder	6.06e-05	9.02e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGF—autistic disorder	6.06e-05	9.02e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PIK3CG—autistic disorder	6.04e-05	8.99e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APC—autistic disorder	6.04e-05	8.99e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—RORA—autistic disorder	6.02e-05	8.95e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGF—autistic disorder	5.97e-05	8.89e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—autistic disorder	5.84e-05	8.68e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—autistic disorder	5.84e-05	8.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—autistic disorder	5.84e-05	8.68e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTEN—autistic disorder	5.8e-05	8.62e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTEN—autistic disorder	5.8e-05	8.62e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTEN—autistic disorder	5.8e-05	8.62e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—autistic disorder	5.75e-05	8.56e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTEN—autistic disorder	5.72e-05	8.5e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—autistic disorder	5.69e-05	8.47e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—autistic disorder	5.67e-05	8.43e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOB—autistic disorder	5.64e-05	8.39e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF1—autistic disorder	5.61e-05	8.35e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF1—autistic disorder	5.61e-05	8.35e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF1—autistic disorder	5.61e-05	8.35e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—autistic disorder	5.57e-05	8.28e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—autistic disorder	5.57e-05	8.28e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—autistic disorder	5.57e-05	8.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1—autistic disorder	5.53e-05	8.23e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—autistic disorder	5.49e-05	8.16e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HRAS—autistic disorder	5.41e-05	8.04e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HRAS—autistic disorder	5.38e-05	8.01e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTEN—autistic disorder	5.36e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTEN—autistic disorder	5.33e-05	7.93e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—autistic disorder	5.33e-05	7.93e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—autistic disorder	5.33e-05	7.93e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—autistic disorder	5.33e-05	7.93e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—autistic disorder	5.26e-05	7.82e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TPH2—autistic disorder	5.24e-05	7.8e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—autistic disorder	5.18e-05	7.7e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DPYD—autistic disorder	5.16e-05	7.67e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—autistic disorder	5.15e-05	7.66e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MAPK1—autistic disorder	5.1e-05	7.59e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MAPK1—autistic disorder	5.1e-05	7.59e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MAPK1—autistic disorder	5.1e-05	7.59e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MAPK1—autistic disorder	5.03e-05	7.49e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—HRAS—autistic disorder	4.99e-05	7.43e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—HRAS—autistic disorder	4.97e-05	7.39e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTEN—autistic disorder	4.85e-05	7.22e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTEN—autistic disorder	4.85e-05	7.22e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTEN—autistic disorder	4.85e-05	7.22e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CACNA1C—autistic disorder	4.79e-05	7.13e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTEN—autistic disorder	4.79e-05	7.12e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—autistic disorder	4.78e-05	7.11e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—autistic disorder	4.76e-05	7.07e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MAPK1—autistic disorder	4.71e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MAPK1—autistic disorder	4.71e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MAPK1—autistic disorder	4.71e-05	7.01e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MAPK1—autistic disorder	4.65e-05	6.91e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DHFR—autistic disorder	4.36e-05	6.49e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MAPK1—autistic disorder	4.35e-05	6.48e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MAPK1—autistic disorder	4.33e-05	6.45e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—autistic disorder	4.31e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—autistic disorder	4.31e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—autistic disorder	4.31e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—autistic disorder	4.25e-05	6.33e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HRAS—autistic disorder	4.1e-05	6.1e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HRAS—autistic disorder	4.1e-05	6.1e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HRAS—autistic disorder	4.1e-05	6.1e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTEN—autistic disorder	4.06e-05	6.04e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTEN—autistic disorder	4.06e-05	6.04e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PTEN—autistic disorder	4.06e-05	6.04e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HRAS—autistic disorder	4.04e-05	6.01e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTEN—autistic disorder	4e-05	5.95e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—autistic disorder	3.92e-05	5.84e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—autistic disorder	3.92e-05	5.84e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—autistic disorder	3.92e-05	5.84e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—autistic disorder	3.87e-05	5.75e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—HRAS—autistic disorder	3.78e-05	5.63e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HRAS—autistic disorder	3.78e-05	5.63e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HRAS—autistic disorder	3.78e-05	5.63e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HRAS—autistic disorder	3.73e-05	5.55e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—autistic disorder	3.62e-05	5.39e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—autistic disorder	3.62e-05	5.39e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—autistic disorder	3.62e-05	5.39e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—autistic disorder	3.57e-05	5.31e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HRAS—autistic disorder	3.5e-05	5.2e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HRAS—autistic disorder	3.48e-05	5.18e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP19A1—autistic disorder	3.42e-05	5.08e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—autistic disorder	3.35e-05	4.98e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—autistic disorder	3.33e-05	4.95e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MAPK1—autistic disorder	3.3e-05	4.91e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MAPK1—autistic disorder	3.3e-05	4.91e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MAPK1—autistic disorder	3.3e-05	4.91e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MAPK1—autistic disorder	3.25e-05	4.84e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—COMT—autistic disorder	3.18e-05	4.73e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTP1—autistic disorder	3.16e-05	4.7e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOA—autistic disorder	3.15e-05	4.69e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—autistic disorder	3.08e-05	4.58e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G4A—autistic disorder	2.9e-05	4.32e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—autistic disorder	2.9e-05	4.32e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX1—autistic disorder	2.78e-05	4.14e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HRAS—autistic disorder	2.65e-05	3.94e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HRAS—autistic disorder	2.65e-05	3.94e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HRAS—autistic disorder	2.65e-05	3.94e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HRAS—autistic disorder	2.61e-05	3.89e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—autistic disorder	2.57e-05	3.82e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—autistic disorder	2.54e-05	3.77e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—autistic disorder	2.54e-05	3.77e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—autistic disorder	2.54e-05	3.77e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—autistic disorder	2.5e-05	3.72e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—autistic disorder	2.39e-05	3.56e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PIK3CG—autistic disorder	2.16e-05	3.21e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—autistic disorder	2.05e-05	3.05e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—autistic disorder	1.64e-05	2.44e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTEN—autistic disorder	1.43e-05	2.12e-05	CbGpPWpGaD
